Mitoxantrone, Etoposide, Carboplatinum and Ara-C Combination Therapy (Meca) in Refractory and Relapsed Acute Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mitoxantrone, Etoposide, Carboplatinum and Ara-C Combination Therapy (Meca) in Refractory and Relapsed Acute Leukemia

Published:2000-01 Issue:5-6 Volume:39 Page:583-590
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ferrá Chkistelle,Berlanga Jcan J.,Gallardo David,AncIan Idoia,MarIan David,Gonzaalez Juan R,Peris Juan,Muñoz Juan,Sarraa Josæ,Grañena Alberto

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428190009113388

Reference28 articles.

1. Acute Myeloid Leukemia

2. Acute Lymphoblastic Leukemia

3. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.

4. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy

5. High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia;Leukemia & Lymphoma;2024-06-06

2. Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review;Annals of Hematology;2018-04-21

3. Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia;Clinical Lymphoma Myeloma and Leukemia;2015-01

4. Overexpression ofMIR9indicates poor prognosis in acute lymphoblastic leukemia;Leukemia & Lymphoma;2013-05-15

5. FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia;Medical Oncology;2010-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3